Treatment of Advanced Bladder Cancer with Adriamycin and 5-Fluorouracil
- 1 December 1976
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 48 (7), 609-615.
- https://doi.org/10.1111/j.1464-410x.1976.tb06708.x
Abstract
The cytotoxic drug combination of adriamycin and 5-fluorouracil has resulted in a 35% objective response in 20 patients with advanced bladder cancer. This has been achieved with minimal toxicity and on an out-patient basis. If the survival rate of patients with invasive bladder cancer is to be improved it seems likely that some form of systemic treatment will need to be added to the local measures currently in use. Further studies of different chemotherapeutic agents should help to define an effective and safe form of adjunvant therapy.Keywords
This publication has 10 references indexed in Scilit:
- Chemotherapy of Bladder Carcinoma with Cyclophosphamide and AdriamycinJournal of Urology, 1975
- The chemotherapy of urologic cancerCancer, 1975
- L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast CancerNew England Journal of Medicine, 1975
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973
- Phase II evaluation of adriamycin in human neoplasiaCancer, 1973
- Adriamycin—an antitumor antibiotic in the treatment of neoplastic diseasesCancer, 1973
- Clinical Trials with Adriamycin. Results of Three-Years StudyPublished by Springer Nature ,1972
- Clinical trials with adriamycinCancer, 1971
- The Radiation AttackPublished by American Medical Association (AMA) ,1969
- Meaningful clinical classification of therapeutic responses to anticancer drugsClinical Pharmacology & Therapeutics, 1961